NBD AI Bulletin - Chongqing Zhifei Biological Products Co Ltd (SZ 300122, close price: 89.86 yuan) released the annual results for 2022 on March 20. Operating income for the year came in at about 38.264 billion yuan, showing an increase of 24.83% from a year earlier. Net profit attributable to the shareholders of the listed company was about 7.539 billion yuan, down 26.15% year on year. Basic earnings per share was about 4.71 yuan, down 26.15%.

In the first half of 2022, the operating income of the Company came from biological products (99.92%).

Chongqing Zhifei Biological Products Co Ltd's chairman and general manager is Jiang Rensheng, male, 70 years old, with a college degree. 

As of press time, the market value of the Company was 143.8 billion yuan.

(By Lan Suying)

Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Please verify before use. Any action you take upon the information on this website is at your own risk.